A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder

Summary

This study is an open-label, parallel group study to evaluate acute pulmonary safety and Pharmacokinetics (PK) of two doses, separated by 2 hours, of CVT-427 zolmitriptan inhalation powder in three groups of adults: those with asthma, those who smoke and healthy volunteers.

Timeline

Start

2016-09

Primary completion

2016-12

Completion

2016-12

Drugs

Indications